TP53 and glioma: Our data clearly demonstrates that exogenous GAB decreases the viability, growth, and proliferation of U87MG and LN229 cells, pointing to the ubiquity of this phenomenon among GBM cell lines originally not expressing GLS2, independently of the TP53/PTEN status of these highly malignant glioma cells.